U.S. Semiconductors Stock News

Wondering whether Blackbaud at around US$37.54 is a bargain or a value trap? This breakdown will help you size up what the current share price really reflects. The stock has been broadly flat over the last month at around 0.0%. However, that sits against a much tougher backdrop with a 36.9% decline year to date and a 38.9% decline over the past year. Those longer term returns mean many holders are sitting on losses, which often pushes valuation questions to the front of investors' minds...

Pro-Dex (PDEX) has put up a solid Q3 2026 print, with revenue of about US$19.9 million and basic EPS of roughly US$1.23, against a trailing twelve month backdrop where earnings grew 28.1% year over year and net profit margin sat at 16.1%. Over recent quarters the company has seen revenue move from around US$17.4 million in Q3 2025 to US$19.9 million in Q3 2026, while quarterly basic EPS ranged between roughly US$0.37 and US$1.43 over that stretch, giving a clear view of how revenue and per...

American International Group (AIG) opened 2026 with Q1 results that put the focus squarely on the income statement, as revenue came in at US$6.7b and basic EPS landed at US$1.42 on net income of US$763m. The company has seen revenue move from US$6.5b in Q1 2025 to US$6.7b in Q1 2026, while basic EPS over that stretch ranged from US$1.18 in Q1 2025 to US$1.42 in the latest quarter. This sets the stage for investors to weigh these headline figures against a backdrop of improving trailing net...

OneSpan (OSPN) Q1 2026 earnings snapshot OneSpan (OSPN) has opened 2026 with Q1 revenue of US$65.9 million and basic EPS of US$0.31, setting the tone for investors assessing how the business is converting its software demand into bottom line results. Over the past year, the company has seen trailing twelve month revenue sit at US$245.8 million with basic EPS of US$1.84, alongside earnings growth of 20.4% and net margins at 28.5% compared to 24% a year earlier. This provides useful context for...

LPL Financial Holdings (LPLA) opened 2026 with Q1 revenue of about US$4.8b and basic EPS of US$4.45, as investors weigh these headline figures against a reported net margin of 5% over the trailing 12 months that was affected by a US$732.0m one off loss. The company has seen quarterly revenue move from US$3.4b in Q4 2024 to US$3.6b in Q1 2025 and then to about US$4.8b in Q1 2026. Over the last six reported periods, trailing 12 month basic EPS has ranged from US$14.17 to US$11.25, placing...

Jade Biosciences (NasdaqCM: JBIO) appointed Edward R. Conner, M.D. as Chief Medical Officer. The company elevated Andrew King, M.D., Ph.D. to President, Research & Development. These leadership changes focus on clinical development, regulatory strategy, and R&D continuity for Jade's autoimmune pipeline. Jade Biosciences, listed on NasdaqCM under the ticker JBIO, is focused on developing therapies for autoimmune conditions, an area that continues to attract capital and partnerships across...

PBF Energy (PBF) opened 2026 with Q1 revenue of US$7.9b and basic EPS of US$1.69, alongside net income excluding extra items of US$198.3m, setting a clear marker after a volatile run of recent quarters. The company has seen quarterly revenue move from US$7.1b in Q1 2025 to US$7.9b in Q1 2026, while EPS shifted from a loss of US$3.53 in Q1 2025 to a profit of US$1.69 in the latest period. This points to a very different margin profile as investors gauge how durable this reset may be. See our...

Wondering whether Delta Air Lines at around US$68.98 is offering good value or stretching expectations? This article will help you size up the stock through a clear valuation lens. The share price has moved by 0.8% over the last 7 days and 2.0% over the last 30 days, with a 1 year return of 58.0% and a 3 year return of 109.5%, while the year to date figure sits at a slight 0.1% decline. Recent headlines have focused on Delta Air Lines in the context of broader airline sector themes,...

Investors may be wondering whether Aurora Innovation's share price reflects its true worth, or if the market is mispricing the story right now. The stock recently closed at US$6.13, with returns of 24.8% over 7 days, 46.7% over 30 days, 58.4% year to date, and a 24.7% decline over the past year, alongside a very large gain over 3 years. Recent coverage has focused on how autonomous driving and AI related names are being reassessed by investors, as attention shifts to companies tied to real...

If you are wondering whether Corcept Therapeutics at around US$51.42 is attractively priced or already stretched, starting with a clear view of valuation can help frame your next move. The stock has seen sharp swings recently, with returns of 11.6% over 7 days, 22.5% over 30 days, 34.6% year to date, but a 29.3% decline over the past year and gains of 113.6% over 3 years and 143.7% over 5 years. Recent coverage has focused on how this price history shapes expectations for Corcept...

For investors considering whether Travelers Companies at around US$304.72 represents fair value or whether the price may be ahead of itself, this article examines what the available numbers indicate about the stock. The share price has moved by 0.7% over the past week, 4.9% over the last month, 6.8% year to date and 15.8% over the past year. These figures provide useful context before assessing the underlying value. Recent news coverage has focused on Travelers Companies as a major U.S...

Why CarGurus Stock Is on Investors’ Radar CarGurus (CARG) has drawn investor interest after recent trading left the shares around US$37.04, with returns over the past month and past 3 months outpacing its year to date performance. See our latest analysis for CarGurus. That recent move to US$37.04 follows a 10.4% 30 day share price return and a 14.3% 90 day share price return, set against a year to date share price return that is slightly negative and a 31.4% 1 year total shareholder return...

NIO (NIO) is back in focus after April deliveries reached 29,356 vehicles and the All New ES8 crossed 100,000 cumulative units, alongside expanded 900V technology collaboration with Onsemi and the Onvo L80 rollout. See our latest analysis for NIO. Despite the recent 1 day share price return of a 7.51% decline to $5.91 and a 7 day share price return of a 4.83% decline, NIO has a 90 day share price return of 25.74% and a 1 year total shareholder return of 46.65%, although the 5 year total...

Omega Healthcare Investors (OHI) opened 2026 with Q1 revenue of US$323 million and basic EPS of US$0.47, alongside funds from operations of US$249 million and FFO per share of US$0.84, setting a clear snapshot of cash generation and earnings at the start of the year. Over the past reported quarters, revenue has moved from US$277 million in Q1 2025 to US$319 million in Q4 2025 and EPS has ranged between US$0.34 and US$0.60 over that period. This gives investors a recent history of how the top...

Wondering if American Healthcare REIT is reasonably priced at around US$50 a share, or if the market is getting ahead of itself? This article walks through what the current numbers actually say about value. The stock recently closed at US$50.15, with returns of 0.1% over 7 days, 5.5% over 30 days, 6.2% year to date and 57.7% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on American Healthcare...

Align Technology (ALGN) opened 2026 with Q1 revenue of about US$1.0 billion and basic EPS of US$1.58, setting the tone for how investors will read the rest of the year. The company has seen quarterly revenue move from US$979.3 million in Q1 2025 through US$995.2 million in Q4 2024 to just over US$1.0 billion in the latest quarter, while basic EPS over the same span ranged from US$1.27 in Q1 2025 to US$1.89 in Q4 2025 before landing at US$1.58 in Q1 2026. This provides a clear run-rate on both...

O'Reilly Automotive (ORLY) opened 2026 with Q1 revenue of US$4.6b and basic EPS of US$0.72, supported by trailing twelve month revenue of US$18.2b and EPS of US$3.08 that point to earnings growth of 9.5% over the past year. Over the last five reported quarters, the company has seen revenue move from US$4.1b in Q1 2025 to US$4.6b in Q1 2026, while quarterly EPS ranged between US$0.63 and US$0.86 across that period as trailing net income reached US$2.6b. With net profit margins running at...

This article examines whether StoneCo, trading at around US$10.98, could be considered a bargain or a value trap by focusing on what the current share price might imply about the company. The stock has experienced significant recent volatility, with a 24.5% decline over the last week, a 22.2% decline over the last month, and a 25.3% decline year to date. Over longer periods, the 1 year return shows a 4.3% decline and the 5 year return a 78.3% decline. Recent commentary around StoneCo has...

Why PulteGroup is on investors’ radar today PulteGroup (PHM) is back on many watchlists after recent share price moves, including a 1.4% gain over the last day, a 6.3% decline over the past week, and mixed returns over the month and past 3 months. See our latest analysis for PulteGroup. That short-term pullback, with a 7 day share price return of a 6.3% decline, sits against a much stronger backdrop that includes a 1 year total shareholder return of 21.1% and a 5 year total shareholder return...

Structure Therapeutics (NasdaqGM:GPCR) plans multiple presentations at the 86th American Diabetes Association Scientific Sessions. The company will share new safety, efficacy, and dosing data for its oral GLP-1 receptor agonist aleniglipron. Additional data will cover a novel amylin receptor agonist combination, including findings on weight loss effects. The presentations focus on combination approaches in obesity and diabetes treatment development. Structure Therapeutics focuses on oral...

If you are wondering whether Camtek's current share price reflects its underlying value, you are not alone. That question is exactly what this article will help you think through. Camtek's stock has been volatile recently, with a 2% decline over the last week, a 26.6% gain over the last 30 days, a 66.2% return year to date, and a 191.3% return over the last year, along with very large multi year gains. These moves have put Camtek firmly on many investors' radars, and recent coverage has...

Wondering if Truist Financial at around US$51.50 is offering good value right now, or if the easy gains are already behind it. The stock recently closed at US$51.50, with returns of 0.2% over 7 days, 12.0% over 30 days, 3.5% year to date, 39.9% over 1 year and 6.8% over 5 years, which provides a range of recent pricing data to consider. Recent coverage around Truist Financial has focused on its position in the U.S. banking sector and how investors are reassessing established banks. This...

Why Southwest Gas Holdings (SWX) is on investors’ radar Southwest Gas Holdings (SWX) has drawn attention after a sustained stretch of positive returns, including gains over the past week, month, past 3 months and year. This performance is prompting investors to reassess the utility’s current share price. See our latest analysis for Southwest Gas Holdings. The recent 1 month share price return of 8.23% and year to date share price return of 17.34% suggest building momentum, while the 1 year...

In recent years, AutoZone's heavy reliance on debt-funded share buybacks has left the company with liabilities that appear to exceed its assets, raising concerns about the durability of a business model that has produced very large long-term returns for shareholders in the past. These worries are being amplified by higher interest rates and the gradual shift toward electric vehicles, which together may challenge AutoZone's historically dependable cash generation and financial flexibility...